CLINICAL_TRIALS ClinicalTrials.gov record update

Unveiling Prognosis Cancer-Associated Thromboembolism Biomarkers and Their Related Polymorphisms: Exploring Their Involvement With Immune Circulating Cells and Therapeutic Reversibility

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06065592
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:32.324833+00:00
Published At: 2023-10-06T00:00:00+00:00
Record Updated At: 2023-10-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cancer", "Solid Tumor", "Thromboembolism", "Cardiovascular Diseases", "Immune System Diseases", "Inflammatory Diseases", "Colon Cancer", "Breast Cancer", "Prostate Cancer", "Hepatocellular Carcinoma", "Lung Cancer", "Chemotherapy", "Immunotherapy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-10-06"
protocolSection.identificationModule.nctId: "NCT06065592"
protocolSection.identificationModule.officialTitle: "Unveiling Prognosis Cancer-Associated Thromboembolism Biomarkers and Their Related Polymorphisms: Exploring Their Involvement With Immune Circulating Cells and Therapeutic Reversibility"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.